Sumitomo Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Sumitomo Life Insurance’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.46M	Sell	7,755 -371	-5%	-$173K	0.08%	84
2025 Q4	$3.68M	Buy	8,126 +1,033	+15%	+$445K	0.1%	88
2025 Q3	$2.78M	Sell	7,093 -143	-2%	-$59.8K	0.09%	100
2025 Q2	$3.22M	Sell	7,236 -301	-4%	-$139K	0.22%	79
2025 Q1	$3.65M	Sell	7,537 -76	-1%	-$35.4K	0.13%	73
2024 Q4	$3.07M	Sell	7,613 -115	-1%	-$53.3K	0.06%	87
2024 Q3	$3.59M	Buy	7,728 +128	+2%	+$61.5K	0.07%	70
2024 Q2	$3.56M	Sell	7,600 -98	-1%	-$42.5K	0.08%	68
2024 Q1	$3.22M	Sell	7,698 -224	-3%	-$94.7K	0.08%	74
2023 Q4	$3.22M	Buy	7,922 +17	+0.2%	+$6.28K	0.1%	66
2023 Q3	$2.75M	Buy	7,905 +118	+2%	+$41.3K	0.08%	64
2023 Q2	$2.74M	Buy	7,787 +2,814	+57%	+$948K	0.12%	66
2023 Q1	$1.57M	Buy	+4,973	New	+$1.49M	0.13%	126

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sumitomo Life Insurance's VRTX Position: Q1 2026 in Review

Sumitomo Life Insurance reduced its Vertex Pharmaceuticals (VRTX) stake by 4.6% in Q1 2026, selling an estimated $173K and leaving 7,755 shares worth $3.46M. The position accounts for 0.08% of the portfolio, ranked #84.

Sumitomo Life Insurance first reported a position in VRTX in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.68M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Sumitomo Life Insurance held 7,755 shares of Vertex Pharmaceuticals worth $3.46M as of Q1 2026.
Sumitomo Life Insurance sold 371 Vertex Pharmaceuticals shares in Q1 2026, an estimated $173K.
Vertex Pharmaceuticals made up 0.08% of Sumitomo Life Insurance's portfolio in Q1 2026, its #84 holding.
Sumitomo Life Insurance first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
Sumitomo Life Insurance's Vertex Pharmaceuticals position peaked at $3.68M in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.